Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP828889.RA7QeUvKu856VVTkmmde-QWVTwJDoDzVUgfOdEuWZaBwY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP828889.RA7QeUvKu856VVTkmmde-QWVTwJDoDzVUgfOdEuWZaBwY130_assertion type Assertion NP828889.RA7QeUvKu856VVTkmmde-QWVTwJDoDzVUgfOdEuWZaBwY130_head.
- NP828889.RA7QeUvKu856VVTkmmde-QWVTwJDoDzVUgfOdEuWZaBwY130_assertion description "[Azacitidine gives encouraging results in Ph-negative MPN having progressed to AML or MDS, but response duration is short, and consolidation treatments have to be evaluated.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP828889.RA7QeUvKu856VVTkmmde-QWVTwJDoDzVUgfOdEuWZaBwY130_provenance.
- NP828889.RA7QeUvKu856VVTkmmde-QWVTwJDoDzVUgfOdEuWZaBwY130_assertion evidence source_evidence_literature NP828889.RA7QeUvKu856VVTkmmde-QWVTwJDoDzVUgfOdEuWZaBwY130_provenance.
- NP828889.RA7QeUvKu856VVTkmmde-QWVTwJDoDzVUgfOdEuWZaBwY130_assertion SIO_000772 20664061 NP828889.RA7QeUvKu856VVTkmmde-QWVTwJDoDzVUgfOdEuWZaBwY130_provenance.
- NP828889.RA7QeUvKu856VVTkmmde-QWVTwJDoDzVUgfOdEuWZaBwY130_assertion wasDerivedFrom befree-2016 NP828889.RA7QeUvKu856VVTkmmde-QWVTwJDoDzVUgfOdEuWZaBwY130_provenance.
- NP828889.RA7QeUvKu856VVTkmmde-QWVTwJDoDzVUgfOdEuWZaBwY130_assertion wasGeneratedBy ECO_0000203 NP828889.RA7QeUvKu856VVTkmmde-QWVTwJDoDzVUgfOdEuWZaBwY130_provenance.